Angiotensin II-induced dilated cardiomyopathy in Balb/c but not C57BL/6J mice

Experimental Physiology

Volumn 96, Issue 8, 2011, Pages 756-764

  Peng, Hongmei ^a   Yang, Xiao Ping ^a   Carretero, Oscar A ^a   Nakagawa, Pablo ^a   D'Ambrosio, Martin ^a   Leung, Pablo ^a   Xu, Jiang ^a   Peterson, Edward L ^a   González, Germán E ^a   Harding, Pamela ^a   Rhaleb, Nour Eddine ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; COLLAGEN;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; HEART DILATATION; HEART EJECTION FRACTION; HEART FUNCTION; HEART FUNCTION TEST; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART RATE; HEART VENTRICLE WALL; HYPERTENSION; LUNG CONGESTION; LUNG WEIGHT; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; ORGAN WEIGHT; OSMOTIC PUMP; PHENOTYPE; SYSTOLIC BLOOD PRESSURE; TISSUE REGENERATION;

EID: 79960699648     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2011.057612     Document Type: Article

References (29)

1. Afanasyeva M, Wang Y, Kaya Z, Park S, Zilliox MJ, Schofield BH, Hill SL & Rose NR (2001). Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. Am J Pathol 159, 193-203.
2. Androulakis ES, Tousoulis D, Papageorgiou N, Tsioufis C, Kallikazaros I & Stefanadis C (2009). Essential hypertension: is there a role for inflammatory mechanisms? Cardiol Rev 17, 216-221.
3. Harding P, Yang XP, He Q & LaPointe MC (2011). Lack of microsomal prostaglandin E synthase-1 reduces cardiac function following angiotensin II infusion. Am J Physiol Heart Circ Physiol 300, H1053-H1061.
4. Haudek SB, Cheng J, Du J, Wang Y, Hermosillo-Rodriguez J, Trial J, Taffet GE & Entman ML (2010). Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy. J Mol Cell Cardiol 49, 499-507.
5. Himmelrich H, Launois P, Maillard I, Biedermann T, Tacchini-Cottier F, Locksley RM, Rocken M & Louis JA (2000). In BALB/c mice, IL-4 production during the initial phase of infection withLeishmania majoris necessary and sufficient to instruct Th2 cell development resulting in progressive disease. J Immunol 164, 4819-4825.
6. Hoffmann KF, McCarty TC, Segal DH, Chiaramonte M, Hesse M, Davis EM, Cheever AW, Meltzer PS, Morse HC 3rd & Wynn TA (2001). Disease fingerprinting with cDNA microarrays reveals distinct gene expression profiles in lethal type 1 and type 2 cytokine-mediated inflammatory reactions. FASEB J 15, 2545-2547.
7. Huber SA & Lodge PA (1986). Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice. Am J Pathol 122, 284-291.
8. Krege JH, Hodgin JB, Hagaman JR & Smithies O (1995). A noninvasive computerized tail-cuff system for measuring blood pressure in mice. Hypertension 25, 1111-1115.
9. +T lymphocytes and association with myocardial HLA-DR expression. J Clin Immunol 26, 33-39.
10. Liao L, Sindhwani R, Leinwand L, Diamond B & Factor S (1993). Cardiac alpha-myosin heavy chains differ in their induction of myocarditis. Identification of pathogenic epitopes. J Clin Invest 92, 2877-2882.
11. Liao YH, Yuan J, Wang ZH, Cheng X, Zhang JH, Tian Y, Dong JH, Guo HP & Wang M (2005). Infectious tolerance to ADP/ATP carrier peptides induced by anti-L3T4 monoclonal antibody in dilated cardiomyopathy mice. J Clin Immunol 25, 376-384.
12. Mills CD, Kincaid K, Alt JM, Heilman MJ & Hill AM (2000). M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 164, 6166-6173.
13. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA & Coffman RL (1986). Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136, 2348-2357.
14. Nishimura H, Okazaki T, Tanaka Y, Nakatani K, Hara M, Matsumori A, Sasayama S, Mizoguchi A, Hiai H, Minato N & Honjo T (2001). Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 291, 319-322.
15. Okura Y, Takeda K, Honda S, Hanawa H, Watanabe H, Kodama M, Izumi T, Aizawa Y, Seki S & Abo T (1998). Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 helper T cells in rats. Circ Res 82, 1035-1042.
16. Paul M, Mehr AP & Kreutz R (2006). Physiology of local renin-angiotensin systems. Physiol Rev 86, 747-803.
17. Paul WE & Seder RA (1994). Lymphocyte responses and cytokines. Cell 76, 241-251.
18. Rogge L (2002). A genomic view of helper T cell subsets. Ann N Y Acad Sci 975, 57-67.
19. Sandler NG, Mentink-Kane MM, Cheever AW & Wynn TA (2003). Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair. J Immunol 171, 3655-3667.
20. Shimizu K, Shichiri M, Libby P, Lee RT & Mitchell RN (2004). Th2-predominant inflammation and blockade of IFN-γ signaling induce aneurysms in allografted aortas. J Clin Invest 114, 300-308.
21. Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M et al. (1992). RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68, 855-867.
22. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V & Egido J (2003). Inflammation and angiotensin II. Int J Biochem Cell Biol 35, 881-900.
23. Sweat F, Puchtler H & Rosenthal SI (1964). Sirius Red F3BA as a stain for connective tissue. Arch Pathol 78, 69-72.
24. 1 antagonists in mice. Hypertension 40, 244-250.
25. Xu Z, Okamoto H, Akino M, Onozuka H, Matsui Y & Tsutsui H (2008). Pravastatin attenuates left ventricular remodeling and diastolic dysfunction in angiotensin II-induced hypertensive mice. J Cardiovasc Pharmacol 51, 62-70.
26. Yang X-P, Liu YH, Rhaleb N-E, Kurihara N, Kim HE & Carretero OA (1999). Echocardiographic assessment of cardiac function in conscious and anesthetized mice. Am J Physiol Heart Circ Physiol 277, H1967-H1974.
27. Yu Q, Horak K & Larson DF (2006). Role of T lymphocytes in hypertension-induced cardiac extracellular matrix remodeling. Hypertension 48, 98-104.
28. Yu Q, Watson RR, Marchalonis JJ & Larson DF (2005). A role for T lymphocytes in mediating cardiac diastolic function. Am J Physiol Heart Circ Physiol 289, H643-H651.
29. Zhang R, Zhang YY, Huang XR, Wu Y, Chung AC, Wu EX, Szalai AJ, Wong BC, Lau CP & Lan HY (2010). C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease. Hypertension 55, 953-960.